Morgane Giordano

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

34

H-Index

1

About

Dr. Morgane Giordano is a leading urologic surgeon and researcher whose work focuses on optimizing perioperative care and outcomes for patients undergoing major oncologic surgery, particularly robot-assisted radical cystectomy. Her most cited study, a 2019 prospective implementation of a nonopioid protocol for patients undergoing this procedure with extracorporeal urinary diversion, has garnered 34 citations and represents a pivotal contribution to enhanced recovery after surgery (ERAS) pathways. By demonstrating the feasibility and safety of minimizing opioid use in this complex patient population, Dr. Giordano has helped advance a paradigm shift toward multimodal, opioid-sparing analgesia in urologic oncology. Her research directly addresses the critical need to reduce postoperative opioid dependence and improve recovery quality. Beyond this landmark work, her broader investigations into surgical techniques, pain management, and patient-reported outcomes continue to shape clinical practice. Dr. Giordano’s commitment to evidence-based, patient-centered innovation makes her a respected voice in the field, and her work serves as a model for integrating rigorous prospective data into real-world surgical protocols.

Research Focus

Key Achievements

1
H-Index
1
Papers
34
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Prospective implementation of a nonopioid protocol for patients undergoing robot-assisted radical cystectomy with extracorporeal urinary diversion
34 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago